Longjin pharmaceutical co.002750
80.660
Investors
Development Strategy

We will continuously improve our research, development and innovation capabilities. With breviscapine for injection as the core, we develop characteristic generic drugs and innovative drugs for the treatment of cardiovascular and cerebrovascular diseases and metabolic diseases. Taking industrial hemp plantation as an opportunity, we carry out the layout on the entire hemp industry chain. We improve the modernization level of traditional Chinese medicine through the smart manufacturing, and continuously improve our management level, talent level and technology level to develop into a modern pharmaceutical company with core competitiveness.


We will inject new vitality into the company through the dual-wheel drive of "internal improvement + external extension". In internal improvement, we will increase R & D investment in the characteristic generic drugs according to the strategic direction, and cooperate with foreign technical teams with mature technologies and domestic high-end R&D institutions through multiple channels to accelerate the marketing of new products that meet our strategic direction. In external extension, we will continuously search suitable targets for product or enterprise mergers and acquisitions in order to expand our scale and product line.


Investment Hatch Platform

Yunnan Longjin Fantian Biotechnology Co., Ltd.


Drugs

Yunnan CAS Longjin Biotechnology Co., Ltd.

Jiangsu Longjin Kangyou Biomedical Co., Ltd.

Jiangsu Longjin Kangyou Biomedical Co., Ltd.

Nanjian Longjin Agricultural Technology Co., Ltd.


Hemp

Yunnan Muya Agricultural Technology Co., Ltd.

http://www.ynmuya.com 

Address: Jinding Science Park, Wuhua District, Kunming


Yunnan Muya Agricultural Technology Co., Ltd. is currently one of legal institutions specialized in large-scale plantation and operation of hemp products in China and an enterprise exclusively engaged in the production and operation of hemp. In 2018, it was selected as one of participators for targeted poverty alleviation by Shizong County People’s Government. The company legally promotes the industrial and medical applications of the hemp to make a positive contribution to the vigorous development of China, and has made great achievements in setting industrial standards and industry specifications. It is an enterprise legally carrying out whole industry layout of hemp.


Muya Agricultural started to plant the industrial hemp in 2016, and obtained Yunnan Hemp Plantation License for the first time in 2016. Muya Agricultural renewed the certificate on April 20, 2018 and obtained the approval for planting hemp in an area of 12 thousand mu (1 mu= 0.0667 hectares). Longjin Pharmaceutical holds 51% shares of Muya Agricultural.


Health Industry

Fujian Longjintang Health Industry Co., Ltd.

http://www.longjintang.cn/

Telephone: +86-592-5752251

Address: Room 1102, Tongda International Building, Guanyin Mountai, Siming District, Xiamen, China


As a holding subsidiary of Longjin Pharmaceutical, Fujian Longjintang Health Co., Ltd. is a new retail platform invested by Longjin Pharmaceutical for mainly selling natural health products. Longjintang adheres to the corporate culture spirit of  "service orientation", implements the values of "creating value and returning to the society", is committed to the cause of great health, and attaches importance to both health and beauty to make every Chinese healthy and beautiful. Longjintang always adheres to the conduct principles of transparency, fairness and safety, provides high-quality market planning to dealers, helps them quickly seize market opportunities to achieve a win-win situation of wealth and health, and makes better achievements to give back to dealers, teams and society.